Patrice Rioux

Neuroscience · Life Sciences

27h-index2.7kcitations66works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

EEG and Brain-Computer Interfaces(8), Biomedical Research and Pathophysiology(8), Neuroscience and Neuropharmacology Research(7), Suicide and Self-Harm Studies(7), Traumatic Brain Injury and Neurovascular Disturbances(7)

Publications66 total

1729TiP Rationale and design of the phase IIb/III VOICE trial of clonidine MBT for the prevention of severe oral mucositis in patients with OPC receiving chemoradiotherapy
Annals of Oncology·2021
Intravenous infusion of iduronidase-IgG and its impact on the central nervous system in children with Hurler syndrome
Molecular Genetics and Metabolism·2017· 8 cited
Controversies and research agenda in nephropathic cystinosis: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Kidney International·2016· 80 cited
Schizophrenia Assessed by Computerized EEG1
Advances in biological psychiatry·2015· 21 cited
Quality of Life is Improved and Kidney Function Preserved in Patients with Nephropathic Cystinosis Treated for 2 Years with Delayed-Release Cysteamine Bitartrate
The Journal of Pediatrics·2014· 54 citedOpen Access
Pharmacokinetic Studies of Cysteamine Bitartrate Delayed‐Release
Clinical Pharmacology in Drug Development·2013· 12 cited
Pharmacokinetics of cysteamine bitartrate following intraduodenal delivery
Fundamental and Clinical Pharmacology·2012· 15 cited
The Effect of Food on Cysteamine Bitartrate Absorption in Healthy Participants
Clinical Pharmacology in Drug Development·2012· 7 cited
Halitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartrate
Molecular Genetics and Metabolism·2012· 27 cited
A0001 in Friedreich ataxia: Biochemical characterization and effects in a clinical trial
Movement Disorders·2012· 89 cited
A Randomized Controlled Crossover Trial with Delayed-Release Cysteamine Bitartrate in Nephropathic Cystinosis
Clinical Journal of the American Society of Nephrology·2012· 93 citedOpen Access
Towards a modern definition of vitamin E—evidence for a quinone hypothesis
Bioorganic & Medicinal Chemistry Letters·2011· 13 cited
120. Correlation of plasma cysteamine and WBC cystine levels at steady state in patients treated with cysteamine bitartrate
Molecular Genetics and Metabolism·2010· 1 cited
Testing drug response in the presence of genetic information
Pharmacogenetics·2001· 1 cited
P01.51 Medical follow-up of attempters in the year preceding suicide
European Psychiatry·2000Open Access
Clinical trials in pharmacogenetics and pharmacogenomics: Methods and applications
American Journal of Health-System Pharmacy·2000· 87 citedOpen Access
Selective Killing of Cancer Cells Based on Loss of Heterozygosity and Normal Variation in the Human Genome: A New Paradigm for Anticancer Drug Therapy
Molecular Pharmacology·1999· 35 cited
Selective Killing of Cancer Cells Based on Loss of Heterozygosity and Normal Variation in the Human Genome: A New Paradigm for Anticancer Drug Therapy
Molecular Pharmacology·1999
Tentativas de suicidio e inseguridad laboral: una asociación compleja
European psychiatry (Ed Española)·1999
Risk factors associated with suicide attempt in young French people
Acta Psychiatrica Scandinavica·1998· 17 cited
page 1 of 4Next →

Frequent Co-authors

Jean‐Claude Baron(18), G Marchal(9), E. Zarifian(7), Francis Eustache(7), B Lechevalier(7), J M Derlon(6), P. Etévenon(6), Vincent de La Sayette(5), Fausto Viader(5), B. Pidoux(5), F. Le Doze(4), Marie-Christine Petit-Taboué(4), Carlo Serrati(4), Elisabeth A. M. Cornelissen(4), Jean Marcel Travère(4), Louisa Barré(4), Ranjan Dohil(4), P Péron-Magnan(4), G Verdeaux(4), Françoise Chastang(4)